Recent health news highlights include a halt in new measles cases in Texas, efforts to accelerate the approval of drugs for ...

The EU faces a surge in new opioids and designer drugs, while the U.S. fast-tracks rare disease drugs. Brazil tackles bird ...

Omada Health shows strong growth and innovation in chronic care but remains unprofitable with valuation, churn. See why OMDA ...

Two sizable issuers went public this past week and featured the best first-day pop for a billion-dollar IPO in Renaissance’s ...

The IPO market is starting to feel healthier. Omada Health, a 14-year-old company providing virtual care for chronic ...

Omada Health went public on the Nasdaq Friday, marking the second digital health company to do so after a post-pandemic ...

Shares of Omada Health finished their trading debut on the Nasdaq above their IPO price after the virtual chronic care firm ...

The team at Omada Health took a victory lap Friday after the company's successful Nasdaq debut, according to company ...

Fresh from a $150 million IPO on Wall Street, Omada Health CEO Sean Duffy shares his thoughts on speed bumps, GLP-1s, staying ...

Omada Health, a 14-year-old digital health company supporting chronic disease patients, has yet to generate profits.

Diabetes care startup Omada Health went public Friday 14 years after its founding. Here's what its major investors' stakes ...